Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 6/20 | 0.53 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | THRA | P10827 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14085627 | 0.89 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL31111470 | 0.89 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL3797840 | 0.89 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL2018917 | 0.89 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL15726531 | 0.89 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL15731929 | 0.89 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL31481564 | 0.89 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL4518941 | 0.88 | SMPD1 (0.61) | SMPD1MGLLTHRATHRB | |
| SCHEMBL28591699 | 0.87 | SMPD1 (0.51) | SMPD1 | |
| SCHEMBL970532 | 0.87 | SMPD1 (0.54) | SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090176995-A1 | Soluble fullerene derivatives | NATIONAL UNIVERSITY CORPORATION NAGOYA INSTITUTE OF TECHNOLOGY (JP) | 2009-07-09 | — | — | US | disclosed |
| US-20090176995-A1 | Soluble fullerene derivatives | NATIONAL UNIVERSITY CORPORATION NAGOYA INSTITUTE OF TECHNOLOGY (JP) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176995-A1 | Soluble fullerene derivatives | SOD1, EPCAM, NDUFV2 | SMPD1 4453/4885MGLL 3264/4885THRA 4590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.